Add Yahoo as a preferred source to see more of our stories on Google. This story was originally published on BioPharma Dive. To receive daily news and insights, subscribe to our free daily BioPharma ...

Add Yahoo as a preferred source to see more of our stories on Google. FILE PHOTO: The Pfizer logo is seen at their world headquarters in Manhattan, New York, U.S. (Reuters) - Pfizer Inc said on Friday ...

Matthew Herper covers medical innovation — both its promise and its perils. Pfizer said Thursday its drug Ibrance showed efficacy in a group of breast cancer patients who do not currently have access ...

On Thursday, Pfizer Inc. (NYSE:PFE) and Alliance Foundation Trials, LLC (AFT) announced results from the Phase 3 PATINA trial. The trial demonstrated that the addition of IBRANCE (palbociclib) to ...

It’s unusual to have the FDA chase down a pharma company and ask them apply for a new drug indication. But Pfizer went through just that and has now quietly revealed a label expansion for blockbuster ...

The U.S. Food and Drug Administration today granted accelerated approval to Ibrance (palbociclib) to treat advanced (metastatic) breast cancer. Breast cancer in women is the second most common type of ...

Approval of expanded indication based predominately on real-world data NEW YORK--(BUSINESS WIRE)-- Pfizer (NYSE:PFE) today announced that the U.S. Food and Drug Administration (FDA) approved a ...

Those were the findings of the phase 3 PALOMA-3 trial, presented May 30 during the 2015 annual meeting of the American Society of Clinical Oncology (ASCO), a gathering of nearly 30,000 oncology ...

Debut ads helped drive the list-toppers for pharma TV spending in February. New commercials in ongoing campaigns for some big drugs, including Pfizer's breast cancer drug Ibrance and Novartis' ...